Literature DB >> 18513161

Variations of clonal marrow stem cell lines established from human bone marrow in surface epitopes, differentiation potential, gene expression, and cytokine secretion.

S U Song1, C S Kim, S P Yoon, S K Kim, M H Lee, J S Kang, G S Choi, S H Moon, M S Choi, Y K Cho, B K Son.   

Abstract

Bone marrow has been considered to contain many different types of progenitor or stem cells. This study aims to establish a new strategy that provides for the rapid establishment of human clonal marrow stem cell (hcMSC) lines with a relatively small amount of bone marrow aspirate and to characterize newly generated hcMSC lines for their cell phenotype, differentiation potential, lineage-specific gene expression, and cytokine secretion. Human cMSC lines were generated with human bone marrow aspirates using a new protocol, called the subfractionation culturing method. The newly established hcMSC lines were analyzed for their cell surface epitopes by fluorescence-activated cell sorting (FACS), differentiation potential by in vitro differentiation assays, lineage-specific gene expression by RT-PCR, and cytokine secretion by enzyme-linked immunoassay (ELISA). The overall profile of the cell-surface epitopes of the newly established hcMSC lines was similar to those of the known MSCs. These hcMSC lines were capable of differentiating into multilineages with some differences in differentiation capability. In addition, these hcMSC lines secrete high levels of transforming growth factor-beta1 (TGF-beta1), leukemia inhibitory factor (LIF), TGF-alpha, and interleukein-10 (IL-10), again with some variation in each cell line. The newly designed protocol may be an efficient method to establish hcMSC lines rapidly with a relatively small amount of bone marrow sample, and these newly established hcMSC lines possess stem cell characteristics and exhibit some differences in cell-surface epitopes, differentiation potential, lineage-specific gene expression, and cytokine secretion.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513161     DOI: 10.1089/scd.2007.0167

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  19 in total

1.  Characterization of mouse clonal mesenchymal stem cell lines established by subfractionation culturing method.

Authors:  Myung-Shin Jeon; Tac-Ghee Yi; Hyun-Ja Lim; Sun-Hwa Moon; Moon-Hee Lee; Joon-Soon Kang; Chul-Soo Kim; Dae-Hyun Lee; Sun U Song
Journal:  World J Stem Cells       Date:  2011-08-26       Impact factor: 5.326

2.  Mesenchymal stromal cells for steroid-refractory acute graft-versus-host disease: a report of two cases.

Authors:  Joo Han Lim; Moon Hee Lee; Hyeon Gyu Yi; Chul Soo Kim; Jun Hyung Kim; Sun U Song
Journal:  Int J Hematol       Date:  2010-06-01       Impact factor: 2.490

Review 3.  Interplay between mesenchymal stem cells and lymphocytes: implications for immunotherapy and tissue regeneration.

Authors:  L Wang; Y Zhao; S Shi
Journal:  J Dent Res       Date:  2012-09-17       Impact factor: 6.116

4.  Interleukin-25 primed mesenchymal stem cells achieve better therapeutic effects on dextran sulfate sodium-induced colitis via inhibiting Th17 immune response and inducing T regulatory cell phenotype.

Authors:  Weizi Cheng; Jingling Su; Yiqun Hu; Qingwen Huang; Huaxiu Shi; Lin Wang; Jianlin Ren
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

5.  Mesenchymal Stem Cell Lines Isolated by Different Isolation Methods Show Variations in the Regulation of Graft-versus-host Disease.

Authors:  Hyun Seung Yoo; Tacghee Yi; Yun Kyoung Cho; Woo Cheol Kim; Sun U Song; Myung-Shin Jeon
Journal:  Immune Netw       Date:  2013-08-26       Impact factor: 6.303

6.  Molecular Characterization of Neurally Differentiated Human Bone Marrow-derived Clonal Mesenchymal Stem Cells.

Authors:  Tacghee Yi; Hyun-Joo Lee; Yun-Kyoung Cho; Myung-Shin Jeon; Sun U Song
Journal:  Immune Netw       Date:  2014-02-21       Impact factor: 6.303

7.  Mesenchymal stem cells infected with Mycoplasma arginini secrete complement C3 to regulate immunoglobulin production in B lymphocytes.

Authors:  D-S Lee; T G Yi; H-J Lee; S-N Kim; S Park; M-S Jeon; S U Song
Journal:  Cell Death Dis       Date:  2014-04-24       Impact factor: 8.469

8.  Non-invasive characterization of the adipogenic differentiation of human bone marrow-derived mesenchymal stromal cells by HS-SPME/GC-MS.

Authors:  Dong-Kyu Lee; TacGhee Yi; Kyung-Eun Park; Hyun-Joo Lee; Yun-Kyoung Cho; Seul Ji Lee; Jeongmi Lee; Jeong Hill Park; Mi-Young Lee; Sun U Song; Sung Won Kwon
Journal:  Sci Rep       Date:  2014-10-09       Impact factor: 4.379

9.  Therapeutic effects of mouse bone marrow-derived clonal mesenchymal stem cells in a mouse model of inflammatory bowel disease.

Authors:  Jin Seok Park; Tac-Ghee Yi; Jong-Min Park; Young Min Han; Jun-Hyung Kim; Dong-Hee Shin; Seon Ji Tak; Kyuheon Lee; Youn Sook Lee; Myung-Shin Jeon; Ki-Baik Hahm; Sun U Song; Seok Hee Park
Journal:  J Clin Biochem Nutr       Date:  2015-10-21       Impact factor: 3.114

10.  Bone marrow-derived clonal mesenchymal stem cells inhibit ovalbumin-induced atopic dermatitis.

Authors:  K Na; H S Yoo; Y X Zhang; M-S Choi; K Lee; T G Yi; S U Song; M-S Jeon
Journal:  Cell Death Dis       Date:  2014-07-17       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.